China Universal Asset Management Co., Ltd. Arcellx, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,466 shares of ACLX stock, worth $781,178. This represents 0.08% of its overall portfolio holdings.
Number of Shares
11,466
Previous 10,339
10.9%
Holding current value
$781,178
Previous $863,000
1.16%
% of portfolio
0.08%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding ACLX
# of Institutions
204Shares Held
44.1MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$273 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$265 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$255 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$240 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$168 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.99B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...